Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience

被引：7

作者：

Schwartz, Jason ^{[1
]}

Thiesset, Heather ^{[2
]}

Box, Terry ^{[3
]}

Hutson, William ^{[4
]}

Sorensen, John ^{[2
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Div Surg Transplantat, Dept Surg, Dallas, TX 75390 USA

[2] Univ Utah, Dept Gen Surg, Sect Transplantat, Salt Lake City, UT USA

[3] Univ Utah, Dept Med, Salt Lake City, UT USA

[4] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA

来源：

LIVER TRANSPLANTATION | 2012年 / 18卷 / 11期

关键词：

D O I：

10.1002/lt.23513

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1395 / 1396

页数：2

共 50 条

[1] Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience
Schwartz, Jason J.
Pappas, Lisa
Thiesset, Heather F.
Vargas, Gabriela
Sorensen, John B.
Kim, Robin D.
Hutson, William R.
Boucher, Kenneth
Box, Terry
LIVER TRANSPLANTATION, 2012, 18 (04) : 423 - 433
[2] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
Levi, David M.
Tzakis, Andreas G.
Martin, Paul
Nishida, Seigo
Island, Eddie
Moon, Jang
Selvaggi, Gennaro
Tekin, Akin
Madrazo, Beatrice L.
Narayanan, Govindarajan
Garcia, Monica T.
Feun, Lynn G.
Tryphonopoulos, Panagiotis
Skartsis, Nikolaos
Livingstone, Alan S.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 727 - 734
[3] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era Discussion
Hemming, Alan W.
Johnson, Lynt
O'Leary, Pat
Perry, Roger
Stain, Steven C.
Levi, David M.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 735 - 736
[4] Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center
Tan, E. K.
Goh, B. K. P.
Lee, S. Y.
Krishnamoorthy, T. L.
Tan, C. K.
Jeyaraj, P. R.
TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3564 - 3570
[5] Impact of Model for End-Stage Liver Disease on Patient Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma
Moonka, D.
Castillo, E.
Kumer, S.
Abouljoud, M.
Divine, G.
Pelletier, S.
TRANSPLANTATION PROCEEDINGS, 2009, 41 (01) : 216 - 218
[6] Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception
Gerber, David A.
Anderson, Christopher D.
Chapman, William C.
Jones, Christopher M.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 230 (04) : 513 - 514
[7] Model for end-stage liver disease (MELD) exception for polycystic liver disease
Arrazola, Luis
Moonka, Dilip
Gish, Robert G.
Everson, Gregory T.
LIVER TRANSPLANTATION, 2006, 12 (12) : S110 - S111
[8] Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
Raza, Muhammad H.
Kwon, Yong
Kobierski, Pierre
Misra, Asish C.
Lim, Angelina
Goldbeck, Cameron
Etesami, Kambiz
Kohli, Rohit
Emamaullee, Juliet
LIVER TRANSPLANTATION, 2023, 29 (02) : 134 - 144
[9] Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma
Young, Kellie
Aguilar, Maria
Gish, Robert
Younossi, Zobair
Saab, Sammy
Bhuket, Taft
Liu, Benny
Ahmed, Aijaz
Wong, Robert J.
LIVER TRANSPLANTATION, 2016, 22 (10) : 1356 - 1366
[10] Center Variation in the Use of Nonstandardized Model for End-Stage Liver Disease Exception Points
Goldberg, David S.
Makar, George
Bittermann, Therese
French, Benjamin
LIVER TRANSPLANTATION, 2013, 19 (12) : 1330 - 1342

← 1 2 3 4 5 →